BMO Capital Starts Korro Bio Inc. (KRRO) at Outperform, 'A Leader In RNA Editing W/ High Potential In AATD & Beyond'

February 27, 2024 2:46 AM EST Send to a Friend
(Updated - February 27, 2024 3:36 AM EST)

BMO Capital analyst Kostas Biliouris initiates coverage on Korro Bio Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login